Development of antibacterial compounds that constrain evolutionary pathways to resistance
Antibiotic resistance is a worldwide challenge. A potential approach to block resistance is to simultaneously inhibit WT and known escape variants of the target bacterial protein. Here, we applied an integrated computational and experimental approach to discover compounds that inhibit both WT and tr...
Main Authors: | Yanmin Zhang, Sourav Chowdhury, João V Rodrigues, Eugene Shakhnovich |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2021-07-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/64518 |
Similar Items
-
Genome comparison of progressively drug resistant Plasmodium falciparum lines derived from drug sensitive clone
by: Ravi Toteja, et al.
Published: (2001-04-01) -
A novel bicyclic 2,4-diaminopyrimidine inhibitor of Streptococcus suis dihydrofolate reductase
by: Warangkhana Songsungthong, et al.
Published: (2021-02-01) -
The Anti-Multidrug-Resistant <i>Acinetobacter baumannii</i> Study on 1,3-diamino-7H-pyrrolo[3,2-f]quinazoline Compounds
by: Han Wu, et al.
Published: (2022-12-01) -
Discovery of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases in Diverse Environmental Settings Suggests an Evolutionary Advantage Unrelated to Antibiotic Resistance
by: Stella Cellier-Goetghebeur, et al.
Published: (2022-12-01) -
The Bacterial Genomic Context of Highly Trimethoprim-Resistant DfrB Dihydrofolate Reductases Highlights an Emerging Threat to Public Health
by: Claudèle Lemay-St-Denis, et al.
Published: (2021-04-01)